RedHill Biopharma Ltd. (RDHL) stock
RDHLNasdaqPharmaceutical Preparations
$0.32−0.03 (-7.63%)
Close on Nov 19, 2026Market cap $1.65MP/E –Yield –
RedHill Biopharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$9.66M. The highest annual figure on record is -$9.38M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.66M | – |
| FY2024 | Dec 31, 2024 | -$9.38M | – |
| FY2023 | Dec 31, 2023 | -$35.83M | – |
| FY2022 | Dec 31, 2022 | -$29.38M | – |
| FY2021 | Dec 31, 2021 | -$65.16M | – |
| FY2020 | Dec 31, 2020 | -$48.99M | – |
| FY2019 | Dec 31, 2019 | -$40.92M | – |
| FY2018 | Dec 31, 2018 | -$34.49M | – |
| FY2017 | Dec 31, 2017 | -$44.92M | – |
| FY2016 | Dec 31, 2016 | -$28.34M | – |
| FY2015 | Dec 31, 2015 | -$17.84M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2022 | Jun 30, 2022 | -$16.74M | – |
| Q2 FY2021 | Jun 30, 2021 | -$18.90M | – |
| Q2 FY2020 | Jun 30, 2020 | -$15.05M | – |
| Q2 FY2019 | Jun 30, 2019 | -$10.58M | – |
| Q2 FY2018 | Jun 30, 2018 | -$8.40M | – |
| Q2 FY2017 | Jun 30, 2017 | -$9.83M | – |
See a number that looks wrong?